Recursion Pharmaceuticals (RXRX) Receivables - Net (2020 - 2023)
Recursion Pharmaceuticals' (RXRX) quarterly Receivables - Net came in at $7.9 million in Q3 2023, up 11.27% on a QoQ basis from $7.1 million in Q2 2023.
Recursion Pharmaceuticals (RXRX) Receivables - Net (2020 - 2023) Analysis & Trends
Recursion Pharmaceuticals (RXRX) has 4 years of Receivables - Net data on file, last reported at $7.9 million in Q3 2023.
- Quarterly Receivables - Net changed N/A year-over-year to $7.9 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $7.9 million (changed N/A YoY) and the FY2021 annual result came in at $34000.0, down 78.21% from the prior year.
- Receivables - Net improved to $7.9 million in Q3 2023, from $7.1 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $7.9 million in Q3 2023 to a low of $21000.0 in Q2 2022.
- A 4-year average of $1.7 million and a median of $49000.0 in 2021 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2021 — Receivables - Net plunged 78.21% — and 2023, when it jumped 33709.52%.
- Tracing RXRX's Receivables - Net over 4 years: stood at $156000.0 in 2020, then sank by 78.21% to $34000.0 in 2021, then slumped by 38.24% to $21000.0 in 2022, then soared by 37519.05% to $7.9 million in 2023.
- The last three Receivables - Net figures came in at $7.9 million (Q3 2023), $7.1 million (Q2 2023), and $21000.0 (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Recursion Pharmaceuticals | 1.69 Bn | 1.14 Bn | -3.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 7.90 Mn |
| Sep 30, 2023 | 7.90 Mn |
| Jun 30, 2023 | 7.10 Mn |
| Jun 30, 2023 | 7.10 Mn |
| Jun 30, 2022 | 21,000.00 |
| Jun 30, 2022 | 21,000.00 |
| Mar 31, 2022 | 34,000.00 |
| Mar 31, 2022 | 34,000.00 |
| Dec 31, 2021 | 34,000.00 |
| Dec 31, 2021 | 34,000.00 |
| Sep 30, 2021 | 34,000.00 |
| Sep 30, 2021 | 34,000.00 |
| Jun 30, 2021 | 49,000.00 |
| Jun 30, 2021 | 49,000.00 |
| Mar 31, 2021 | 71,000.00 |
| Mar 31, 2021 | 71,000.00 |
| Dec 31, 2020 | 156,000.00 |
| Dec 31, 2020 | 156,000.00 |